Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database †.
Saved in:
| Title: | Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database †. |
|---|---|
| Authors: | Chiang, Lawrence1 (AUTHOR), Bodzin, Adam1,2 (AUTHOR), Lin, Daniel2,3 (AUTHOR), Hanna, Nader1 (AUTHOR), Koeneman, Scott1,2 (AUTHOR), Dang, Hien1,3 (AUTHOR), Yeo, Charles J.1 (AUTHOR), Shubert, Christopher3 (AUTHOR), Zheng, Richard1 (AUTHOR) Richard.Zheng@jefferson.edu |
| Source: | Cancers. Jul2026, Vol. 18 Issue 13, p2137. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18132137 |
